Key Takeaways Bio-Techne boosts growth via acquisitions, new CAR-T tools and Alzheimer's biomarker assay partnerships.Bio-Techne posts steady global growth, with China leading on double-digit demand across its portfolio.Rising costs, tariffs, and intensified competition create pressure on TECH's margins and growth.Bio-Techne (TECH) continues to expand its portfolio and enter adjacent markets via acquisitions and strategic investments. Strength in international markets underscores the company’s growth potent ...